Not only does the cytokine dampen immune surveillance, but it also blunts the anti-tumor therapeutic effect of chemotherapeutic agents via drug-induced NLRP3 activation in MDSC as well (29, 38) (Table 1). Here, NLRP3 is linked to neoplasm.